The impact of granulocyte colony stimulating factor on patients receiving chimeric antigen receptor T-cell therapy

Am J Hematol. 2021 Oct 1;96(10):E399-E402. doi: 10.1002/ajh.26313. Epub 2021 Aug 14.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antigens, CD19 / therapeutic use*
  • Biological Products
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Immunotherapy, Adoptive
  • Lymphoma, Follicular / therapy
  • Lymphoma, Large B-Cell, Diffuse / therapy*
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Antigens, CD19
  • Biological Products
  • Granulocyte Colony-Stimulating Factor
  • axicabtagene ciloleucel